Cecile Bonnet-Gonnet
9Patents
4h-index
20Co-inventors
53Inventor score
Filing activity: Feb 26, 2001 → Mar 25, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8679540B2 | Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications | Human Necessities | 52 | Active |
| USRE46686E1 | Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications | General | 34 | Active |
| US6437040B1 | Water-soluble block copolymers comprising a hydrophilic block and a hydrophobic block | Chemistry; Metallurgy | 26 | Expired |
| US8236353B2 | Self-precipitating pharmaceutical formulations for the modified release of an active principle | Human Necessities | 4 | Active |
| US7439292B2 | Use of block copolymers bearing phosphate and/or phosphonate functions as adhesion promoters or as protecting agents against the corrosion of a metallic surface | Chemistry; Metallurgy | 4 | Expired |
| US6727204B1 | Use of crosslinked polymers as anti-leaching agents | Human Necessities | 1 | Expired |
| US8716217B2 | Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof | Human Necessities | 1 | Active |
| US7169309B2 | Polysaccharides with oxime or amine functions which are used for water treatment and sludge conditioning | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8481019B2 | Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.